The global gene therapy market was valued at approximately USD 5.54 billion in 2023 and is projected to experience significant growth at a compound annual growth rate (CAGR) of 18.88% from 2024 to 2030. This growth is driven by several key factors, including the expanding scope of advanced therapies, innovations in gene delivery technologies, and the increasing competition among leading...

Retinal Gene Therapy Market Overview The Retinal Gene Therapy Market is expanding rapidly, driven by advances in genetic research, rising prevalence of retinal disorders, and increased investment in gene-based treatments. Retinal gene therapy aims to correct genetic mutations that cause vision loss by delivering functional genes directly to the eye,...